XML 11 R39.htm IDEA: XBRL DOCUMENT v2.4.0.6
Earnings Per Share (Details) (USD $)
In Thousands, except Per Share data, unless otherwise specified
3 Months Ended
Mar. 31, 2012
Mar. 31, 2011
Basic net income (loss) attributable to Vertex per common share calculation:    
Net income (loss) attributable to Vertex common shareholders $ 91,590 $ (176,096)
Less: Undistributed earnings allocated to participating securities (906)  
Net income (loss) attributable to Vertex common shareholders-basic 90,684 (176,096)
Basic weighted-average common shares outstanding 208,018 202,329
Basic net income (loss) attributable to Vertex per common share (in dollars per share) $ 0.44 $ (0.87)
Diluted net income (loss) attributable to Vertex per common share calculation:    
Net income (loss) attributable to Vertex common shareholders 91,590 (176,096)
Less: Undistributed earnings allocated to participating securities (860)  
Plus: Interest expense and amortization of deferred issuance costs related to convertible senior subordinated notes 3,749  
Net income (loss) attributable to Vertex common shareholders-diluted $ 94,479 $ (176,096)
Weighted-average shares used to compute basic net income (loss) per common share (in shares) 208,018 202,329
Effect of potentially dilutive securities:    
Convertible senior subordinated notes 8,891  
Stock Options 2,289  
Other 66  
Weighted-average shares used to compute diluted net income (loss) per common share (in shares) 219,264 202,329
Diluted net income (loss) attributable to Vertex per common share (in dollars per share) $ 0.43 $ (0.87)
Stock options.
   
Antidilutive Securities Excluded from Computation of Earnings Per Share    
Antidilutive securities excluded from computation of earnings per share (in shares) 13,768 22,453
Convertible senior subordinated notes.
   
Antidilutive Securities Excluded from Computation of Earnings Per Share    
Antidilutive securities excluded from computation of earnings per share (in shares)   8,192
Unvested restricted stock and restricted stock units
   
Antidilutive Securities Excluded from Computation of Earnings Per Share    
Antidilutive securities excluded from computation of earnings per share (in shares) 16 2,206